Skip to content
buyModerate cluster of 2

GILEAD SCIENCES, INC. bought $20M of ASMB

owner at ASSEMBLY BIOSCIENCES, INC.. 940,499 shares at an average of $21.37, traded Dec 19, 2024, filed Dec 23, 2024.

Conviction score
50
Value
$20M
940,499 shares
Holdings after
2,209,471
+74% from before
From 52-week low
-
no price yet
From 52-week high
-
no price yet

What happened after comparable buys

Same side and tier, against the S&P 500, at 1, 3 and 6 months. Shown to Pro users; the whole table is on the backtest page.

Price, last year

ASMB, daily close, last year. insider buy insider sellDot size follows the dollar value (largest $20M).

Rows in this filing

Every transaction in Form 4 0000904454-24-000669, as filed. Open on EDGAR

DateTransactionSharesPriceValueHoldings afterFiled
Dec 19, 2024POpen-market purchase
Common Stock
+940,499$21.37$20M2,209,471Dec 23, 2024

Related signals

Other insiders at ASSEMBLY BIOSCIENCES, INC. and this insider’s other filings.

ScoreSideCompanyInsiderValueSharesFiled
38Weakbuy 2ASMB
ASSEMBLY BIOSCIENCES, INC.
Houghton Michael
director
$50k3,202
22WeakbuyASMB
ASSEMBLY BIOSCIENCES, INC.
Schornstein Alexander
owner
$372k25,000
15WeaksellASMB
ASSEMBLY BIOSCIENCES, INC.
White Nicole S
Chief Manufacturing Officer
$65240

Not investment advice. Scores and forward returns are decision support built from public SEC filings and past prices; they describe what happened after comparable filings, not what will happen after this one. Do your own research and size your risk.

GILEAD SCIENCES, INC. bought $20M of ASMB | InsiderTell